Lynx1 Capital Management LP Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$279.2B
Holdings
14
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (14 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | GHRSGH RESEARCH PLC | 6,443,940 | $71.1B | 25.45% | |
| 2 | MRUSMERUS N V | 1,568,841 | $66.0B | 23.65% | |
| 3 | PTGXPROTAGONIST THERAPEUTICS INC | 733,014 | $35.4B | 12.69% | |
| 4 | STOKSTOKE THERAPEUTICS INC | 5,291,929 | $35.2B | 12.60% | |
| 5 | CGEMCULLINAN THERAPEUTICS INC | 3,215,722 | $24.3B | 8.72% | |
| 6 | ALLOALLOGENE THERAPEUTICS INC | 11,057,009 | $16.1B | 5.78% | |
| 7 | CCCCC4 THERAPEUTICS INC | 7,098,133 | $11.4B | 4.07% | |
| 8 | TCRXTSCAN THERAPEUTICS INC | 5,357,347 | $7.4B | 2.65% | |
| 9 | DTILPRECISION BIOSCIENCES INC | 766,051 | $3.7B | 1.31% | |
| 10 | IBIOIBIO INC | 862,279 | $3.5B | 1.24% | |
| 11 | PASGPASSAGE BIO INC | 9,256,953 | $3.3B | 1.17% | |
| 12 | UPBUPSTREAM BIO INC | 219,247 | $1.3B | 0.48% | |
| 13 | NEUPNEUPHORIA THERAPEUTICS INC | 45,806 | $263.8M | 0.09% | |
| 14 | DSGNDESIGN THERAPEUTICS INC | 65,954 | $254.6M | 0.09% |